Scientists Use Gene Editing to Study How Influenza A Virus Infects Human Cells

Medical News: Understanding the Influenza A Virus and Host Interactions
Influenza A virus (IAV) continues to pose a significant threat to public health worldwide due to its ability to cause seasonal epidemics and occasional pandemics. While extensive research has been conducted on how the virus spreads and evolves, scientists are still uncovering the complex interactions between the virus and human cells. A recent study led by researchers from the University of Massachusetts Chan Medical School-USA has used CRISPR gene-editing technology to investigate specific human genes that either help or hinder the ability of influenza A virus to infect human cells.


Scientists Use Gene Editing to Study How Influenza A Virus Infects Human Cells
 
This Medical News report explores how the researchers identified three key host factors - CMAS, B4GALNT2, and ADAR1 - that play a crucial role in the virus's ability to enter and replicate within human cells. By selectively modifying these genes in human lung cells, the scientists were able to determine their effects on viral infection, potentially paving the way for new treatments to combat influenza.
 
The Role of CRISPR in Identifying Host Factors
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a powerful gene-editing tool that allows scientists to precisely modify genes in living cells. In this study, researchers used CRISPR to either deactivate or overexpress specific genes in human bronchial epithelial A549 cells, a common laboratory model for studying respiratory infections. By observing how these genetic changes affected the ability of influenza A virus to infect cells, they gained valuable insights into which genes are essential for the virus's life cycle.
 
Key Findings from the Study
-CMAS Gene Deletion Limits Virus Entry
One of the key findings of the study was that knocking out the CMAS gene significantly reduced the ability of the virus to bind to and enter human cells. The CMAS gene is responsible for producing an enzyme involved in the synthesis of sialic acid, a sugar molecule found on the surface of human cells that influenza A virus uses as a receptor. Without sufficient sialic acid, the virus struggles to attach to cells, thereby reducing infection rates. Importantly, this effect was specific to influenza A virus and did not impact other RNA viruses like vesicular stomatitis virus (VSV).
 
-B4GALNT2 Overexpression Reduces Infection
Another crucial discovery involved the B4GALNT2 gene, which encodes an enzyme that modifies surface molecules on cells. When researchers used CRISPR to increase the expression of this gene, they found that it similarly restricted influenza A virus infection. The mechanism behind this effect appears to involve changes in cell-surface binding properties that prevent the virus from efficiently attaching to cells. This finding suggests that enhancing B4GALNT2 expression could be a potential antiviral strategy.
 
-ADAR1& rsquo;s Dual Role in Viral Infection
The third gene analyzed in the study, ADAR1 (Adenosine Deaminase Acting on RNA 1), exhibited more complex effects on viral infections. Unlike CMAS and B4GALNT2, overexpression of ADAR1 did not significantly reduce influenza A virus replication. However, it did have a notable impact on another virus - coxsackie B virus (CVB), where ADAR1 overexpression increased viral replication. This suggests that ADAR1 may play different roles in regulating various viruses, likely by altering how cells respond to viral RNA.
 
Implications for Influenza Treatment
The findings from this study provide important insights into the biological mechanisms that allow influenza A virus to infect human cells. By identifying specific genes that either promote or inhibit viral infection, scientists can explore new therapeutic approaches. For example, targeting the CMAS gene or enhancing B4GALNT2 expression could serve as potential strategies to prevent influenza infections without relying solely on traditional antiviral drugs or vaccines.
 
Moreover, the dual role of ADAR1 in different viral infections highlights the complexity of host-virus interactions. While ADAR1 may not be a suitable target for combating influenza A virus, its role in enhancing coxsackie B virus infection warrants further research, particularly in understanding how it influences the immune response.
 
Study Limitations and Future Research
While the study provided valuable findings, there are limitations to consider. The experiments were conducted in laboratory-grown human lung cells, which may not fully replicate the complexity of an actual human respiratory tract. Future studies will need to investigate how these genetic modifications impact influenza infection in more physiologically relevant models, such as animal studies or human organoid systems.
 
Additionally, since influenza A virus continuously evolves, further research is needed to determine whether different viral strains interact differently with the identified host factors. Understanding these variations could be crucial for developing broad-spectrum antiviral strategies that remain effective against emerging flu strains.
 
Conclusion
This groundbreaking study demonstrates how CRISPR gene-editing technology can be used to better understand how influenza A virus interacts with human cells. The findings reveal that eliminating the CMAS gene or enhancing B4GALNT2 expression can significantly reduce viral infection by limiting the virus’s ability to attach to host cells. Meanwhile, the effects of ADAR1 suggest that some host factors may play varying roles depending on the type of virus involved.
 
These discoveries offer new directions for antiviral research and could contribute to the development of novel therapeutic strategies against influenza. While further studies are necessary, this research provides a critical foundation for designing future treatments that target host factors instead of the virus itself, potentially reducing the risk of resistance and improving long-term antiviral effectiveness.
 
The study findings were published in the peer-reviewed journal: Microbiology Spectrum.
https://journals.asm.org/doi/10.1128/spectrum.02627-24
 
For the latest on Influenza, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/singapore-scientists-offer-groundbreaking-insights-into-how-respiratory-microbiomes-shift-during-influenza-and-covid-19
 
https://www.thailandmedical.news/news/influenza-mutations-and-drug-resistance-in-focus
 
https://www.thailandmedical.news/news/influenza-news-study-shows-that-cadmium-linked-to-more-severe-influenza-and-pneumonia-infections-and-maybe-covid-19-too
 
https://www.thailandmedical.news/articles/influenza-or-flu
 
https://www.thailandmedical.news/articles/h5n1-avian-flu